Substance Abuse Treatment, Prevention, and Policy最新文献

{"title":"Comparing the effectiveness of in-person vs. virtual intensive group interventions for healthcare professionals with substance use disorders.","authors":"Enric Llavayol, Regina Santiago, Gemma Nieva, Sílvia Torrent, Carmen Buenaventura, Sergi Valero, Constanza Daigre, Xulián Mozo, Josep Antoni Ramos-Quiroga, María Dolores Braquehais","doi":"10.1186/s13011-026-00723-8","DOIUrl":"https://doi.org/10.1186/s13011-026-00723-8","url":null,"abstract":"<p><strong>Background: </strong>Virtual interventions for patients with substance use disorders (SUDs), including intensive outpatient treatment, were developed during the COVID-19 pandemic and later maintained in some clinical settings. However, the effectiveness of this type of intervention in healthcare professionals (HPs) has not been studied so far.</p><p><strong>Methods: </strong>This is a quasi-experimental cohort study with both retrospective and prospective data comparing the main treatment outcomes of HPs in treatment for SUDs: (1) 29 patients following a 40-hour synchronous virtual group intervention; and, (2) 31 patients following a an 80-hour in-person group psychotherapy. They both underwent in-person psychiatric and psychological individual treatment as well as addictive drug use monitoring. Logistic regression analyses were performed to find predictors of abstinence from addictive substances and of working status. A Cox proportional hazards regression was used to compare time to first lapse (positive addictive drug use monitoring). Satisfaction rates at the end of each intervention were also compared in both groups using a non-parametric test.</p><p><strong>Results: </strong>The sample consisted of 60 HPs, with a mean age of 49.5 years (range: 30-67). Of these, 53.3% (n = 32) were women. Physicians represented 53.3% of all patients. Patients in the virtual group were more likely to be working during the intervention compared with those in the in-person group. At one-year follow-up, 55% of the sample remained abstinent from addictive substances. After multivariate analysis, the type of intervention did not predict abstinence when controlling for other variables, although having dual diagnosis was inversely correlated with remaining abstinent (OR: 0.24; 95% CI: 0.07-0.85). HPs receiving in-person intervention were more likely to be working one year after the treatment (OR = 8.3; 95% CI: 2.1-33.3). Time to first lapse was similar between groups, although the in-person sample showed a more heterogeneous distribution. Satisfaction rates were similar in both groups.</p><p><strong>Conclusions: </strong>Virtual interventions may be an effective alternative to in-person interventions for HPs with SUDs. More studies are needed to more deeply analyze these preliminary findings.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147857235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Health insurance type moderates the association between substance use disorders and cardiovascular multimorbidity among U.S. adults - Results from the 2023 National Survey on Drug use and Health.","authors":"Kevin M Ball, Elizabeth C Prom-Wormley, Jonathan L Wells, Anika L Hines","doi":"10.1186/s13011-026-00705-w","DOIUrl":"https://doi.org/10.1186/s13011-026-00705-w","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular multimorbidity (CVD MM), defined as two or more cardiovascular conditions, poses a significant public health challenge. Substance use disorders (SUDs) may elevate CVD MM risk, and health insurance disparities could exacerbate this relationship. We examined if insurance type moderates the association between SUDs and CVD MM.</p><p><strong>Methods: </strong>We analyzed cross-sectional data from 45,133 US adults in the 2023 National Survey on Drug Use and Health (NSDUH). CVD MM was defined as two or more specific cardiovascular conditions. SUDs included illicit drugs and cannabis, excluding nicotine dependence and alcohol use disorder. Logistic regression models examined the SUDs-CVD MM relationship and tested for an interaction between insurance type and SUDs, adjusting for covariates.</p><p><strong>Results: </strong>Individuals in the representative sample of US adults were 60.8% privately insured, 17.4% with Medicaid, 9.1% with Medicare, 8.7% uninsured, and 4.0% with other types of insurance. CVD MM (12.7% Uninsured to 47.7% Medicare; p < 0.0001) and SUDs (2.8% Medicare to 8.3% Medicaid; p < 0.0001) prevalence varied significantly by insurance type. In adjusted models, SUDs were not associated with CVD MM; however, Medicaid enrollees had higher odds of CVD MM than those privately insured. In interaction models, insurance type was a statistically significant moderator of the SUDs-CVD MM association (p = 0.0146). Stratified models showed uninsured adults with SUDs had higher odds of CVD MM (aOR:2.25, 95% CI:1.28,3.93) compared to uninsured counterparts without SUDs. No significant association was found among privately insured, Medicaid, or other insured individuals.</p><p><strong>Conclusions: </strong>Uninsured individuals with SUDs face an elevated risk of CVD MM. Interventions improving access to care for this vulnerable population are crucial for reducing cardiovascular health disparities.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":"21 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147842905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Kava (Piper methysticum) consumption patterns and conceptualizations: results from an online survey.","authors":"Katherine Hill, Cianna Piercey, Hollis C Karoly, Kirsten E Smith","doi":"10.1186/s13011-026-00728-3","DOIUrl":"https://doi.org/10.1186/s13011-026-00728-3","url":null,"abstract":"<p><strong>Background: </strong>'Kava,' or 'kava kava,' (Piper methysticum) is a psychoactive plant indigenous to the Pacific Islands. Historical consumption is reported to provide anxiolytic and sedating effects. In regions where kava is native, it has been used in religious and cultural practices, as well as for medicinal purposes. The mechanisms by which kavalactones - the best studied psychoactive constituent of kava - may mediate pharmacological effects include enhancing the GABA_A receptor, blocking of sodium and calcium channels, blocking reuptake of norepinephrine dopamine, and inhibiting MAO-B. In the United States, products containing kava have proliferated in recent years alongside the rise of ethnobotanical tea bars serving kava preparations.</p><p><strong>Methods: </strong>Between December-July 2024, an anonymous online survey on legal psychoactive products was conducted using convenience sampling. Eligible individuals had to be ≥ 18 years old and endorse lifetime use of kratom, kava, tianeptine, and/or akuamma seed.</p><p><strong>Results: </strong>Of the 368 participants, almost half (n = 180, 48.9%) had used kava during their lifetime. Those who reported lifetime use of kava were younger on average (p = 0.001), more racially diverse (p = 0.041), and had a higher proportion of being employed or in school (p = 0.012) than those where did not use kava in their lifetime. Kava was purchased online (40.6%) or in ethnobotanical tea bars (31.7%). Many reported infrequent consumption (average = 4.4 months/year and 9.1 days/30 days). Lifetime use of alcohol, kratom, and cannabis was common. Approximately one-third of participants had consumed kava more than 100 times, with commonly reported perceived effects from kava experienced in the minutes and hours after consumption included reduced general anxiety (33.7%), improved mood (32.9%), reduced social anxiety (25.5%), and sedation (23.4%). Most respondents had favorable conceptualizations of kava, with only 11.7% characterizing that kava alone as habit-forming. Many (51.7%) conceptualized kava as an alcohol replacement with 18.3% and 16.7% using kava as a short- and/or long-term substitute for alcohol, respectively.</p><p><strong>Conclusions: </strong>Kava use practices are diverse, though perceived kava effects appear mostly mild. The proliferation and diversification of kava products pre-mixed with other psychoactive botanicals requires study as the benefit-risk profile may change. Clinicians should be aware of kava use for harm-reduction and other purposes.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147842886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Does media channel matter? exploring the disparities of online and offline anti-tobacco messages and their impacts on e-cigarette harm perception and use.","authors":"Sha Sarah Qiu, Luxi Zhang, Muhan Liu, Xinshu Zhao, Song Ao","doi":"10.1186/s13011-026-00717-6","DOIUrl":"10.1186/s13011-026-00717-6","url":null,"abstract":"","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":"21 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13127053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147781442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Awareness about opioids crisis, policies and regulation of opioid stewardship at hospitals settings: a nationwide cross-sectional study among healthcare professionals from Pakistan.","authors":"Hafsa Arshad, Ali Hassan Gillani, Jamshaid Ur Rehman, Manthar Ali Mallah, Muhammad Arshed, Yu Fang","doi":"10.1186/s13011-025-00689-z","DOIUrl":"https://doi.org/10.1186/s13011-025-00689-z","url":null,"abstract":"","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147781355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Context-dependent asymmetries in intertemporal decision-making: a comparative study of substance use disorder and control groups.","authors":"Hao Zhang, Shinian Ou, Huoyin Zhang, Cunfeng Yuan, Peng Lei","doi":"10.1186/s13011-026-00729-2","DOIUrl":"https://doi.org/10.1186/s13011-026-00729-2","url":null,"abstract":"","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147781372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A hospital-based multi-centric observational study to explore the prevalence and correlates of non-medical use and dependence of pregabalin among the patients with substance use disorder in Punjab & Chandigarh.","authors":"Jitender Aneja, Neeru Bala, Ajeet Sidana, Rohit Garg, Sandeep Goyal, Sharanjot Kaur, Lokesh Goyal, Ira Domun, Rahul Bangar, Madhur Verma, Bharat Udey, Jawahar Singh","doi":"10.1186/s13011-026-00730-9","DOIUrl":"https://doi.org/10.1186/s13011-026-00730-9","url":null,"abstract":"<p><strong>Background and aim: </strong>Pregabalin (a Gabapentinoid) has been shown to have potential for non-medical use. We aimed at exploring the prevalence and clinical correlates of non-medical use of pregabalin and dependence in patients seeking treatment for substance use disorders (SUDs).</p><p><strong>Materials and methods: </strong>Patients with ICD-10 diagnosis for various SUDs, in the age range of 18-70 years who consented for participation in this study were evaluated for non-medical use and dependence of pregabalin across three different regions of Punjab and the union territory of Chandigarh. ICD-10 criteria for a dependence syndrome (three or more criteria) were used for defining dependence on pregabalin.</p><p><strong>Results: </strong>Out of a total 974 patients enrolled in this study, 44.6% of study participants were using pregabalin and 24.8% fulfilled ICD-10 criteria for a dependence syndrome. Compared to study subjects having non-medical use of pregabalin, a significant number of persons using pregabalin in dependent fashion consumed pregabalin with a frequency of more than 3 times/day (p < 0.001), with daily consumption of pregabalin in doses more than 1200 mg/day (p < 0.001) and suffered from seizures (p < 0.001). Significantly high rates of pregabalin non-medical use and dependence were observed in Sikh patients (p < 0.01), living in rural areas (p < 0.01), who were unmarried/single (p < 0.001), educated more than 10 years (p < 0.01), and with an opioid use disorder (p < 0.001). Pregabalin non-medical use and dependence were also significantly higher in younger patients (p < 0.001), with a younger age of onset of substance use disorder (p = 0.014) and with shorter duration of substance use (p < 0.001). The odds of use of pregabalin were higher in patients with opioid use disorder (aOR = 5.3, 95% CI 3.5-7.9; p < 0.001) in comparison to those with alcohol use disorder.</p><p><strong>Conclusion: </strong>These high estimates for non-medical use and dependence of pregabalin in our study are an early indication of rising problem of pregabalin use amongst the patients with substance use disorders. We draw attention of the healthcare providers and policy makers in formulation of strategies to screen for pregabalin non-medical use and dependence, formulate treatment strategies and devise policy changes to address diversion of pregabalin in view of its non-medical use potential.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147700240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Community-level perceptions of housing services for people with opioid use disorder: a qualitative analysis of community stakeholders in the HEALing communities study.","authors":"Nishita Dsouza, Mary Russo, Dawn Goddard-Eckrich, Diana Hernandez, Nasim Sabounchi, David Lounsbury, Patrick Fowler, Shoshana N Benjamin, Aimee N C Campbell, Anindita Dasgupta, Nabila El-Bassel, Louisa Gilbert","doi":"10.1186/s13011-025-00683-5","DOIUrl":"10.1186/s13011-025-00683-5","url":null,"abstract":"","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":"21 1","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13085672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147692178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Do theory of planned behaviour constructs change during adolescent alcohol use onset?","authors":"Richard Cooke, Geraldine Mabille, Frode Adolfsen, Roman Koposov, Henriette Kyrrestad","doi":"10.1186/s13011-026-00726-5","DOIUrl":"https://doi.org/10.1186/s13011-026-00726-5","url":null,"abstract":"","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147654691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Higher risk cannabis use indicators among people living in Canada: a cross-sectional study examining the association with socio-demographic and socio-economic factors.","authors":"Samantha Goodman, Matthew Dann, Hanan Abramovici","doi":"10.1186/s13011-026-00722-9","DOIUrl":"10.1186/s13011-026-00722-9","url":null,"abstract":"","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2026-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13126716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147628762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}